Medical Devices; number of pages: 131; status: published; publishing date: 01-Nov-23

    • Europe Lung Cancer Screening Market Forecast to 2030

    • Europe Lung Cancer Screening Market Forecast to 2030 – Regional Analysis – by Cancer Type [Non-Small Cell Lung Cancer (NSCLC) and Small Cell Lung Cancer], Technology [Low-Dose Computed Tomography (LDCT), Chest X-Ray, Liquid Biopsy, and Others], Age Group (50 & Older and Below 50), and End User (Hospitals, Diagnostic Centers, and Others)
    • $2,100 – $3,500